RCH4 is another compound that seems to reduce the progression of ALS. In fact in some publication, it indicates to be better than Rilutek(Riluzole) and Radicava(ederavone) in controlling the progression of ALS (MND).

The problem I see with this drug is that getting access may be a problem. It is being provided by a charity organization, and the site purports to represent a “group of retired scientists and doctors” in Europe who “discovered a previously unknown protein … which promotes ALS” and “designed a drug which safely stops production of the problem protein”. Also since they did not have proper funding, the drug has not gone for the FDA approval phase unlike Rilutek and Ederavone.